Showing results (1861-1870 of 1,949) with videos related to

Sort By:
Pageof 195
Nature Chemical Biology|March 28, 2017
Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphataseStephanie M Stanford, Alexander E Aleshin, Vida Zhang, et al.
Cancers|October 14, 2023
Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong KongOtto C H Tam, Ronnie S L Ho, Shing Chan, et al.
Molecules and Cells|September 15, 2000
Analysis of expressed sequence tags from Brassica rapa L. ssp. pekinensisJ Y Lim, C S Shin, E J Chung, et al.
Human Molecular Genetics|November 28, 2017
De novo mutations in Caudal Type Homeo Box transcription Factor 2 (CDX2) in patients with persistent cloacaJacob S J Hsu, Manting So, Clara S M Tang, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Smooth Muscle Dysfunction Drives Cerebrovascular Reserve Failure and End-Organ Brain InjuryTakahiko Imai, Vijai Krishnan, James H Lai, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
Scientific Reports|February 7, 2018
Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathiesGordon K C Leung, H M Luk, Vincent H M Tang, et al.
Journal of Medicinal Chemistry|July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitroJanina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2013
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesS M Lim, H Chang, M J Yoon, et al.
Molecular Genetics & Genomic Medicine|May 1, 2020
The KLHL40 c.1516A>C is a Chinese-specific founder mutation causing nemaline myopathy 8: Report of six patients with pre- and postnatal phenotypesKit San Yeung, Florrie N Y Yu, Cheuk Wing Fung, et al.
Pageof 195